# Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

Study · id `cardio:ct-nct07439133` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07439133](<https://clinicaltrials.gov/study/NCT07439133>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07439133

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 395 participants.

## Technical summary

Registry record NCT07439133. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-11-14 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 395 participants (planned count; ClinicalTrials.gov record NCT07439133, source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)
- Started: 2025-11-14 (actual) (ClinicalTrials.gov record NCT07439133, source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07439133, source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT07439133, source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07439133, source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07439133-2026-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
- Condition: Coronary Artery Disease(CAD)
- Intervention (Drug): XTR004
- Lead sponsor: Sinotau Pharmaceutical Group
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 6e6ece3fc6f3893774acd84d3e82dff4696b437cd0dd8a40af309aa7c58eb03e
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
